Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
European Journal of Medicinal Chemistry
|
May 12, 2019
Ligand retargeting by binding site analogy
Lars Wiedmer, Claude Schärer, Dimitrios Spiliotopoulos, et al.
Analytical Chemistry
|
February 5, 2019
A Reader-Based Assay for m<sup>6</sup>A Writers and Erasers
Lars Wiedmer, Stefanie Alexandra Eberle, Rajiv Kumar Bedi, et al.
Journal of Chemical Theory and Computation
|
January 21, 2021
Atomistic and Thermodynamic Analysis of N6-Methyladenosine (m<sup>6</sup>A) Recognition by the Reader Domain of YTHDC1
Yaozong Li, Rajiv Kumar Bedi, Lars Wiedmer, et al.
Journal of Chemical Theory and Computation
|
November 1, 2019
Flexible Binding of m<sup>6</sup>A Reader Protein YTHDC1 to Its Preferred RNA Motif
Yaozong Li, Rajiv Kumar Bedi, Lars Wiedmer, et al.
Chemmedchem
|
March 12, 2020
Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer
Rajiv K Bedi, Danzhi Huang, Stefanie A Eberle, et al.
Journal of Medicinal Chemistry
|
June 5, 2015
Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain
Andrea Unzue, Min Xu, Jing Dong, et al.
ACS Chemical Biology
|
February 27, 2020
Selectively Disrupting m<sup>6</sup>A-Dependent Protein-RNA Interactions with Fragments
Rajiv Kumar Bedi, Danzhi Huang, Lars Wiedmer, et al.
Chemmedchem
|
July 8, 2021
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes
Elena V Moroz-Omori, Danzhi Huang, Rajiv Kumar Bedi, et al.
The Journal of General Virology
|
July 28, 2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir
Marie O Pohl, Idoia Busnadiego, Francesco Marrafino, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers
Aymeric Dolbois, Laurent Batiste, Lars Wiedmer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
European Journal of Medicinal Chemistry
|
May 12, 2019
Ligand retargeting by binding site analogy
Lars Wiedmer, Claude Schärer, Dimitrios Spiliotopoulos, et al.
Analytical Chemistry
|
February 5, 2019
A Reader-Based Assay for m<sup>6</sup>A Writers and Erasers
Lars Wiedmer, Stefanie Alexandra Eberle, Rajiv Kumar Bedi, et al.
Journal of Chemical Theory and Computation
|
January 21, 2021
Atomistic and Thermodynamic Analysis of N6-Methyladenosine (m<sup>6</sup>A) Recognition by the Reader Domain of YTHDC1
Yaozong Li, Rajiv Kumar Bedi, Lars Wiedmer, et al.
Journal of Chemical Theory and Computation
|
November 1, 2019
Flexible Binding of m<sup>6</sup>A Reader Protein YTHDC1 to Its Preferred RNA Motif
Yaozong Li, Rajiv Kumar Bedi, Lars Wiedmer, et al.
Chemmedchem
|
March 12, 2020
Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer
Rajiv K Bedi, Danzhi Huang, Stefanie A Eberle, et al.
Journal of Medicinal Chemistry
|
June 5, 2015
Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain
Andrea Unzue, Min Xu, Jing Dong, et al.
ACS Chemical Biology
|
February 27, 2020
Selectively Disrupting m<sup>6</sup>A-Dependent Protein-RNA Interactions with Fragments
Rajiv Kumar Bedi, Danzhi Huang, Lars Wiedmer, et al.
Chemmedchem
|
July 8, 2021
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes
Elena V Moroz-Omori, Danzhi Huang, Rajiv Kumar Bedi, et al.
The Journal of General Virology
|
July 28, 2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir
Marie O Pohl, Idoia Busnadiego, Francesco Marrafino, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers
Aymeric Dolbois, Laurent Batiste, Lars Wiedmer, et al.
Page
of 2